Alan Russell
Förmögenhet: 799 344 $ per 2026-05-31
Förmögenhet: 799 344 $ per 2026-05-31
Alan Russell is the founder of Edgewise Therapeutics, Inc., founded in 2017, where the title held is Director & Chief Scientific Officer.
Former jobs include Associate Director-Muscle Biology & Therapeutics at Cytokinetics, Inc. from 2002 to 2010, and VP & Head-Muscle Metabolism Discovery Performance at GlaxoSmithKline LLC from 2014 to 2017.
Education includes undergraduate and doctorate degrees from the University of Bath.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 23 400 ( 0,02 % ) | 799 344 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Grundare | 2017-01-01 |
| Företag | Position | Slut |
|---|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Direktör/Styrelseledamot | 2014-09-01 |
| CYTOKINETICS, INCORPORATED | Företagsledare/Principal | 2010-02-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån